|
1
|
Romanska HM and Berditchevski F:
Tetraspanins in human epithelial malignancies. J Pathol. 223:4–14.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zöller M: Tetraspanins: Push and pull in
suppressing and promoting metastasis. Nat Rev Cancer. 9:40–55.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yu Y, Liang C, Wang S, Zhu J, Miao C, Hua
Y, Bao M, Cao Q, Qin C, Shao P and Wang Z: CD151 promotes cell
metastasis via activating TGF-β1/Smad signaling in renal cell
carcinoma. Oncotarget. 9:13313–13323. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang Z, Wang C, Zhou Z, Sun M, Zhou C,
Chen J, Yin F, Wang H, Lin B, Zuo D, et al: CD151-mediated adhesion
is crucial to osteosarcoma pulmonary metastasis. Oncotarget.
7:60623–60638. 2016.PubMed/NCBI
|
|
5
|
Ke AW, Zhang PF, Shen YH, Gao PT, Dong ZR,
Zhang C, Cai JB, Huang XY, Wu C, Zhang L, et al: Generation and
characterization of a tetraspanin CD151/integrin α6β1-binding
domain competitively binding monoclonal antibody for inhibition of
tumor progression in HCC. Oncotarget. 7:6314–6322. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Palmer TD, Martínez CH, Vasquez C, Hebron
KE, Jones-Paris C, Arnold SA, Chan SM, Chalasani V, Gomez-Lemus JA,
Williams AK, et al: Integrin-free tetraspanin CD151 can inhibit
tumor cell motility upon clustering and is a clinical indicator of
prostate cancer progression. Cancer Res. 74:173–187. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zeng P, Wang YH, Si M, Gu JH, Li P, Lu PH
and Chen MB: Tetraspanin CD151 as an emerging potential poor
prognostic factor across solid tumors: A systematic review and
meta-analysis. Oncotarget. 8:5592–5602. 2017.PubMed/NCBI
|
|
8
|
Enzinger FM: Clear-cell sarcoma of tendons
and aponeuroses. An analysis of 21 cases. Cancer. 18:1163–1174.
1965. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chung EB and Enzinger FM: Malignant
melanoma of soft parts. A reassessment of clear cell sarcoma. Am J
Surg Pathol. 7:405–413. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Andreou D and Tunn PU: Sentinel node
biopsy in soft tissue sarcoma. Recent Results Cancer Res.
179:25–36. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Andreou D, Boldt H, Werner M, Hamann C,
Pink D and Tunn PU: Sentinel node biopsy in soft tissue sarcoma
subtypes with a high propensity for regional lymphatic
spread-results of a large prospective trial. Ann Oncol.
24:1400–1405. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mavrogenis A, Bianchi G, Stavropoulos N,
Papagelopoulos P and Ruggieri P: Clinicopathological features,
diagnosis and treatment of clear cell sarcoma/melanoma of soft
parts. Hippokratia. 17:298–302. 2013.PubMed/NCBI
|
|
13
|
Egawa Y, Saigo C, Kito Y, Moriki T and
Takeuchi T: Therapeutic potential of CPI-613 for targeting tumorous
mitochondrial energy metabolism and inhibiting autophagy in clear
cell sarcoma. PLoS One. 13:e01989402018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Testa JE, Brooks PC, Lin JM and Quigley
JP: Eukaryotic expression cloning with an antimetastatic monoclonal
antibody identifies a tetraspanin (PETA-3/CD151) as an effector of
human tumor cell migration and metastasis. Cancer Res.
59:3812–3820. 1999.PubMed/NCBI
|
|
15
|
Sonobe H, Furihata M, Iwata J, Ohtsuki Y,
Mizobuchi H, Yamamoto H and Kumano O: Establishment and
characterization of a new human clear-cell sarcoma cell-line,
HS-MM. J Pathol. 169:317–322. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sonobe H, Takeuchi T, Taguchi T, Shimizu
K, Iwata J, Furihata M and Ohtsuki Y: Further characterization of
the human clear cell sarcoma cell line HS-MM demonstrating a
specific t(12;22)(q13;q12) translocation and hybrid EWSR1/ATF-1
transcript. J Pahol. 187:594–597. 1999.
|
|
17
|
Takeuchi T, Kuro-o M, Miyazawa H, Ohtsuki
Y and Yamamoto H: Transgenic expression of a novel thymic
epithelial cell antigen stimulates abberant development of
thymocytes. J Immunol. 159:726–733. 1997.PubMed/NCBI
|
|
18
|
Takeuchi T, Adachi Y, Sonobe H, Furihata M
and Ohtsuki Y: A ubiquitin ligase, skeletrophin, is a negative
regulator of melanoma invasion. Oncogene. 25:7059–7069. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Towbin H, Staehelin T and Gordon J:
Electrophoretic transfer of proteins from polyacrylamide gels to
nitrocellulose sheets: Procedure and some applications. Proc Natl
Acad Sci USA. 76:4350–4354. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kito Y, Saigo C and Takeuchi T: Novel
transgenic mouse model of polycystic kidney disease. Am J Pathol.
187:1916–1922. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Morikawa A, Takeuchi T, Kito Y, Saigo C,
Sakuratani T, Futamura M and Yoshida K: Expression of beclin-1 in
the microenvironment of invasive ductal carcinoma of the breast:
Correlation with prognosis and the cancer-stromal interaction. PLoS
One. 10:e01257622015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takeuchi T, Adachi Y and Nagayama T: A
WWOX-binding molecule, transmembrane protein 207, is related to the
invasiveness of gastric signet-ring cell carcinoma. Carcinogenesis.
33:548–554. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Takeuchi T, Misaki A, Liang SB, Tachibana
A, Hayashi N and Sonobe H: Expression of T-cadherin (CDH13,
H-cadherin) in human brain and its characteristics as a negative
growth regulator of epidermal growth factor in neuroblastoma cells.
J Neurochem. 74:1489–1497. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Heussen C and Dowdle EB: Electrophoretic
analysis of plasminogen activators in polyacrylamide gels
containing sodium dodecyl sulfate and copolymerized substrates.
Anal Biochem. 102:196–202. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hong IK, Jin YJ, Byun HJ, Jeoung DI, Kim
YM and Lee H: Homophilic interactions of Tetraspanin CD151
up-regulate motility and matrix metalloproteinase-9 expression of
human melanoma cells through adhesion-dependent c-Jun activation
signaling pathways. J Biol Chem. 281:24279–24292. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Z, Wang F, Li Q, Zhang H, Cui Y, Ma
C, Zhu J, Gu X and Sun Z: CD151 knockdown inhibits osteosarcoma
metastasis through the GSK-3β/β-catenin/MMP9 pathway. Oncol Rep.
35:1764–1770. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shi GM, Ke AW, Zhou J, Wang XY, Xu Y, Ding
ZB, Devbhandari RP, Huang XY, Qiu SJ, Shi YH, et al: CD151
modulates expression of matrix metalloproteinase 9 and promotes
neoangiogenesis and progression of hepatocellular carcinoma.
Hepatology. 52:183–196. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li P, Zeng H, Qin J, Zou Y, Peng D, Zuo H
and Liu Z: Effects of tetraspanin CD151 inhibition on A549 human
lung adenocarcinoma cells. Mol Med Rep. 11:1258–1265. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mii Y, Miyauchi Y, Hohnoki K, Maruyama H,
Tsutsumi M, Dohmae K, Tamai S, Konishi Y and Yamanouchi T: Neural
crest origin of clear cell sarcoma of tendons and aponeuroses.
Ultrastructural and enzyme cytochemical study of human and nude
mouse-transplanted tumours. Virchows Arch A Pathol Anat
Histopathol. 415:51–60. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yamada K, Ohno T, Aoki H, Semi K, Watanabe
A, Moritake H, Shiozawa S, Kunisada T, Kobayashi Y, Toguchida J, et
al: EWS/ATF1 expression induces sarcomas from neural crest-derived
cells in mice. J Clin Invest. 123:600–610. 2013.PubMed/NCBI
|
|
32
|
Zucman J, Delattre O, Desmaze C, Epstein
AL, Stenman G, Speleman F, Fletchers CD, Aurias A and Thomas G: EWS
and ATF-1 gene fusion induced by t(12;22) translocation in
malignant melanoma of soft parts. Nat Genet. 4:341–345. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Davis IJ, Kim JJ, Ozsolak F, Widlund HR,
Rozenblatt-Rosen O, Granter SR, Du J, Fletcher JA, Denny CT,
Lessnick SL, et al: Oncogenic MITF dysregulation in clear cell
sarcoma: Defining the MiT family of human cancers. Cancer Cell.
9:473–484. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Antoniou G, Lee ATJ, Huang PH and Jones
RL: Olaratumab in soft tissue sarcoma-Current status and future
perspectives. Eur J Cancer. 92:33–39. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kohno M, Hasegawa H, Miyake M, Yamamoto T
and Fujita S: CD151 enhances cell motility and metastasis of cancer
cells in the presence of focal adhesion kinase. Int J Cancer.
97:336–343. 2002. View Article : Google Scholar : PubMed/NCBI
|
